NCT06894576View on ClinicalTrials.gov

Development of a Risk Stratification Score for Recurrent Venous Thromboembolism and Treatment-related Clinically Relevant Bleeding in Patients With Cancer-associated Thrombosis

RecruitingOBSERVATIONAL
Enrollment

1,000

Participants

Timeline

Start Date

December 3, 2024

Primary Completion Date

December 31, 2027

Study Completion Date

December 31, 2027

Conditions
Cancer-associated Thrombosis
Trial Locations (1)

K1H8L6

RECRUITING

Ottawa Hospital Research Institute, Ottawa

Sponsors
All Listed Sponsors
collaborator

Canadian Institutes of Health Research (CIHR)

OTHER_GOV

lead

Ottawa Hospital Research Institute

OTHER